Liquid Biopsy Market to Witness High CAGR by 2027: Biocept, Bio-Rad Laboratories, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Genomic Health, Inivata, MDxHealth, QIAGEN, and Thermo Fisher Scientific

The liquid biopsy market is anticipated to grow in the forecast, owing to increasing prevalence of cancer cases across the globe and the rising preference for a non-invasive method of detection. In addition, the R&D activities and strong product pipeline are expected to offer significant growth opportunities in the market during the forecast period.

Liquid biopsy is a non-invasive method used as an alternative for surgical biopsy procedures for the detection of cancer. This technique enables doctors to gather essential information regarding the tumor through samples such as, urine, blood or other bio fluids. Liquid biopsy helps in early detection of cancer and hence can also be used to deliver personalized cancer therapy for every patient and every kind of cancer. Liquid biopsy analyzes DNA, which can give accurate information regarding the presence of mutations in cancer-specific genes.

Get PDF sample copy: https://bit.ly/2I279Mo

The report analyzes factors affecting liquid biopsy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the liquid biopsy market in these regions.

The prominent players profiled in this report are Biocept, Bio-Rad Laboratories, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Genomic Health, Inivata, MDxHealth, QIAGEN, and Thermo Fisher Scientific.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global liquid biopsy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The liquid biopsy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Inquire for Discount: https://bit.ly/2VTH9aL

The global liquid biopsy market is segmented on the basis of product & services, sample, circulating biomarkers, application and end user. Based on product & services, the market is segmented as, equipment, reagents & kits and services. The liquid biopsy market is categorized based on sample such as, blood based, urine based and other sample. On the basis of circulating biomarker, the market is classified as, Circulating Tumor Cells (CTC), exosomes and free nucleic acid. The liquid biopsy market is segmented based on applications such as, Noninvasive Prenatal Testing (NIPT), oncology, transplant diagnostics and other applications. Similarly, based on end user, the market is segmented as, academic & research institutes, hospitals, reference laboratories and other end users.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.